Zobrazeno 1 - 10
of 367
pro vyhledávání: '"A. von Heydebreck"'
Autor:
D’Angelo, S.P., Lebbé, C., Mortier, L., Brohl, A.S., Fazio, N., Grob, J.-J., Prinzi, N., Hanna, G.J., Hassel, J.C., Kiecker, F., von Heydebreck, A., Güzel, G., Nghiem, P.
Publikováno v:
In ESMO Open May 2024 9(5)
Autor:
Reck, Martin, Barlesi, Fabrice, Yang, James Chih-Hsin, Westeel, Virginie, Felip, Enriqueta, Özgüroğlu, Mustafa, Dols, Manuel Cobo, Sullivan, Richard, Kowalski, Dariusz M., Andric, Zoran, Lee, Dae Ho, Sezer, Ahmet, Hu, Ping, Wang, XiaoZhe, von Heydebreck, Anja, Jacob, Natalia, Mehr, Keyvan Tadjalli, Park, Keunchil
Publikováno v:
In Journal of Thoracic Oncology February 2024 19(2):297-313
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Ulrich Keilholz, Janice M. Mehnert, Sebastian Bauer, Hugues Bourgeois, Manish R. Patel, Donald Gravenor, John J. Nemunaitis, Matthew H. Taylor, Lucjan Wyrwicz, Keun-Wook Lee, Vijay Kasturi, Kevin Chin, Anja von Heydebreck, James L. Gulley
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-13 (2019)
Abstract Background We report phase 1b data from patients enrolled in the JAVELIN Solid Tumor clinical trial (NCT01772004) with unresectable stage IIIC or IV melanoma that had progressed after ≥1 line of therapy for metastatic disease. Patients and
Externí odkaz:
https://doaj.org/article/f697bdfa85314d5baa3633869a3141f3
Autor:
Christophe Le Tourneau, Christopher Hoimes, Corrine Zarwan, Deborah J. Wong, Sebastian Bauer, Rainer Claus, Martin Wermke, Subramanian Hariharan, Anja von Heydebreck, Vijay Kasturi, Vikram Chand, James L. Gulley
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 6, Iss 1, Pp 1-9 (2018)
Abstract Background We assessed the efficacy and safety of avelumab, an anti-programmed death ligand 1 (PD-L1) antibody, in patients with previously treated metastatic adrenocortical carcinoma (mACC). Methods In this phase 1b expansion cohort, patien
Externí odkaz:
https://doaj.org/article/a4ceab0673434817a6195d71e7e0f67e
Autor:
Howard L. Kaufman, Jeffery S. Russell, Omid Hamid, Shailender Bhatia, Patrick Terheyden, Sandra P. D’Angelo, Kent C. Shih, Céleste Lebbé, Michele Milella, Isaac Brownell, Karl D. Lewis, Jochen H. Lorch, Anja von Heydebreck, Meliessa Hennessy, Paul Nghiem
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 6, Iss 1, Pp 1-7 (2018)
Abstract Background Merkel cell carcinoma (MCC) is a rare, aggressive skin cancer associated with poor survival outcomes in patients with distant metastatic disease (mMCC). In an initial analysis from JAVELIN Merkel 200, a phase 2, prospective, open-
Externí odkaz:
https://doaj.org/article/8702b9ace3ed4ea195be94aaa6b2d065
Autor:
Kaufman, Howard L, Russell, Jeffery, Hamid, Omid, Bhatia, Shailender, Terheyden, Patrick, D'Angelo, Sandra P, Shih, Kent C, Lebbé, Céleste, Linette, Gerald P, Milella, Michele, Brownell, Isaac, Lewis, Karl D, Lorch, Jochen H, Chin, Kevin, Mahnke, Lisa, von Heydebreck, Anja, Cuillerot, Jean-Marie, Nghiem, Paul
Publikováno v:
In The Lancet Oncology October 2016 17(10):1374-1385
Autor:
Sandra D'Angelo, Celeste Lebbé, Laurent Mortier, Andrew Brohl, Nicola Fazio, Jean-jaques Grob, Natalie Prinzi, Glenn Hanna, Jessica Hassel, Felix Kiecker, Anja von Heydebreck, Gülseren Güzel, Paul Nghiem
Publikováno v:
Regular and Young Investigator Award Abstracts.
Autor:
Douillard, Jean-Yves, Pirker, Robert, O’Byrne, Kenneth J., Kerr, Keith M., Störkel, Stephan, von Heydebreck, Anja, Grote, Hans Jürgen, Celik, Ilhan, Shepherd, Frances A.
Publikováno v:
In Journal of Thoracic Oncology May 2014 9(5):717-724
Autor:
Pirker, Robert, Pereira, Jose R, von Pawel, Joachim, Krzakowski, Maciej, Ramlau, Rodryg, Park, Keunchil, de Marinis, Filippo, Eberhardt, Wilfried EE, Paz-Ares, Luis, Störkel, Stephan, Schumacher, Karl-Maria, von Heydebreck, Anja, Celik, Ilhan, O'Byrne, Kenneth J
Publikováno v:
In Lancet Oncology 2012 13(1):33-42